That all depends...how much people are willing to sell
That all depends...how much people are willing to sell their shares for...if people are dumb and there are plenty, they will dump into the MM's hands in trips possibly 001. that means the short cover will get filled at some point if enough people are selling low.. However, It's not an issue about how high but how much a shareholder(s) is willing to hold out for.
I'm the seller and you're the buying. I'm asking 0009 for my shares and you put a bid in for 0009. you get them. The next min someone puts a buy order in for 002. if I happen to have shares avail at 002 they get filled. Meantime because there is a huge outstanding short position waiting to cover; You me and everyone else including the shorts will be competing for the shares. This is why it went grey in the first place. they couldn't cover in the otc so they got it pushed down into the greys "thinking" people will dump to get out and they get their money.
You really won't know what price we open at or where the price will go until the market opens for trading. It will be erratic and there could be huge price swings during. Eventually it will settle down and stabilize.
now regarding the short interest. If almost everyone held off and kept their limit orders at .25+ in theory the mm's would have to pay that because they HAVE to cover. There would be no shares available to sell for anything less.
Does it mean your shares at .25 will get bought up to cover? well that depends on how many sh decide to sell for much less. The price fluctuations are no longer dependant on MM's control and where the chart it. it's strictly peer to peer trading. price is anyone guess now.
For certain we are in a company that is real backed by assets which are real so we aren't a typical suspended grey sheet. many grey sheet company's operate very successful businesses. So there is no reason for PDXP not to do the same.
1
PDX Partners Inc (PDXP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Top 5 Most Recently Viewed Articles
Dividend Announcement by Safe and Green Development Corporation Safe and Green Development Corporation (NASDAQ: SGD) has recently shared important updates regarding its stock dividend. These updates include confirmation of the trading date on a stock dividend-adjusted basis and details of the dividend share distribution. Details of the Stock Dividend On an earlier date,...
Continue Reading
Understanding Your Rights as a Revance Therapeutics Investor Investing in pharmaceuticals can be both rewarding and risky. If you're an investor in Revance Therapeutics, Inc., it's crucial to stay informed about your rights and the recent allegations surrounding the company. The current situation offers you the opportunity to seek compensation for any potential losses...
Continue Reading
Curbio CEO Rick Rudman Honored by HousingWire Curbio, a leading home improvement company that serves real estate agents, is excited to share that its CEO, Rick Rudman, has been named a recipient of the prestigious 2024 HousingWire Vanguards Award. This award celebrates outstanding leaders who have made a significant impact on their organizations, especially in navigating...
Continue Reading
CoinShares and Vine Hill Capital: A Strategic Merger CoinShares International Limited, a prominent asset manager focused on digital assets, has revealed its plans for a significant corporate transition. In collaboration with Vine Hill Capital Investment Corp., a listed special purpose acquisition company on the Nasdaq Stock Market, CoinShares is set to undergo a strategic...
Continue Reading
Intel Corporation's Current Market Standing Roth/MKM has reaffirmed a neutral outlook on Intel Corporation (NASDAQ: INTC), keeping the price target for its shares at $25.00. This decision comes after Intel's recent announcements about improvements in its foundry manufacturing capabilities and its strategic approach to managing its overall portfolio. Strategic Focus and...
Continue Reading
